title: American society of clinical oncology clinical practice guideline update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer.
abstract: ASCO's technology assessment of the use of aromatase inhibitors in the adjuvant setting was last updated in 2004. ASCO's Update Committee on Aromatase Inhibitors reconvened in May 2009 to update this guideline.
authors.affiliation: Dana-Farber Cancer Institute, Boston, MA; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; American Society of Clinical Oncology, Alexandria, VA.
authors.forename: Harold J
authors.initials: HJ
authors.lastname: Burstein
authors.forename: Jennifer J
authors.initials: JJ
authors.lastname: Griggs
authors.forename: Ann A
authors.initials: AA
authors.lastname: Prestrud
authors.forename: Sarah
authors.initials: S
authors.lastname: Temin